High-throughput transcription profiling identifies putative epigenetic regulators of hematopoiesis

Blood

Volumn 123, Issue 17, 2014, Pages

  Prasad, Punit ^a   Rönnerblad, Michelle ^a   Arner, Erik ^b,c   Itoh, Masayoshi ^b,c,d   Kawaji, Hideya ^b,c,d   Lassmann, Timo ^b,c   Daub, Carsten O ^b,c   Forrest, Alistair R R ^b,c   Lennartsson, Andreas ^a   Ekwall, Karl ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b Division of Genomic Technologies   (Japan)

^c RIKEN YOKOHAMA INSTITUTE   (Japan)

^d RIKEN   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLTRANSFERASE; BRM PROTEIN; CHAPERONE; DNA METHYLTRANSFERASE; DNA METHYLTRANSFERASE 1; DNA METHYLTRANSFERASE 3A; DNA METHYLTRANSFERASE 3B; E1A ASSOCIATED P300 PROTEIN; HISTONE DEACETYLASE; HISTONE DEACETYLASE 1; HISTONE DEACETYLASE 2; HISTONE DEACETYLASE 4; HISTONE DEACETYLASE 5; HISTONE LYSINE METHYLTRANSFERASE; LYSINE; POLYCOMB GROUP PROTEIN; SIRTUIN 1; SIRTUIN 2; SIRTUIN 5;

ACUTE LYMPHOBLASTIC LEUKEMIA; ANIMAL CELL; ARTICLE; BLOOD CELL; BONE MARROW CELL; CELL LINEAGE; CELL TYPE; CELLS; CHROMATIN ASSEMBLY AND DISASSEMBLY; DENDRITIC CELL; EOSINOPHIL; EPIGENETICS; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETIC ANALYSIS; GENETIC REGULATION; GENETIC TRANSCRIPTION; GRANULOCYTE; HEMATOPOIESIS; HEMATOPOIETIC CELL; HEMATOPOIETIC STEM CELL; HEREDITY; HISTONE MODIFICATION; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; LYMPHOCYTE; LYMPHOID CELL; MACROPHAGE; MONOCYTE; MOUSE; NATURAL KILLER CELL; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; TRANSCRIPTION INITIATION; CELL DIFFERENTIATION; DNA METHYLATION; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; GENETICS; METABOLISM; PHYSIOLOGY; PRINCIPAL COMPONENT ANALYSIS;

CELL DIFFERENTIATION; CELL LINEAGE; DNA METHYLATION; EPIGENESIS, GENETIC; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HEMATOPOIESIS; HEMATOPOIETIC STEM CELLS; HUMANS; PRINCIPAL COMPONENT ANALYSIS; TRANSCRIPTION, GENETIC;

EID: 84899618529     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2013-02-483537     Document Type: Article

References (56)

1. Gurish MF, Austen KF. Developmental origin and functional specialization of mast cell subsets. Immunity. 2012;37(1):25-33.
2. Laiosa CV, Stadtfeld M, Graf T. Determinants of lymphoid-myeloid lineage diversification. Annu Rev Immunol. 2006;24:705-738.
3. Suzuki H, Forrest AR, van Nimwegen E, et al FANTOM Consortium; Riken Omics Science Center. The transcriptional network that controls growth arrest and differentiation in a human myeloid leukemia cell line. Nat Genet. 2009;41(5):553-562.
4. Mizuno S, Chijiwa T, Okamura T, et al. Expression of DNA methyltransferases DNMT1, 3A, and 3B in normal hematopoiesis and in acute and chronic myelogenous leukemia. Blood. 2001;97(5): 1172-1179. (Pubitemid 32183737)
5. Galm O, Herman JG, Baylin SB. The fundamental role of epigenetics in hematopoietic malignancies. Blood Rev. 2006;20(1):1-13. (Pubitemid 43106714)
6. Niehrs C, Schäfer A. Active DNA demethylation by Gadd45 and DNA repair. Trends Cell Biol. 2012;22(4):220-227.
7. Clapier CR, Cairns BR. The biology of chromatin remodeling complexes. Annu Rev Biochem. 2009; 78:273-304.
8. Bruserud O, Stapnes C, Tronstad KJ, Ryningen A, Anensen N, Gjertsen BT. Protein lysine acetylation in normal and leukaemic haematopoiesis: HDACs as possible therapeutic targets in adult AML. Expert Opin Ther Targets. 2006;10(1):51-68. (Pubitemid 43263266)
9. Fraga MF, Ballestar E, Villar-Garea A, et al. Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer. Nat Genet. 2005;37(4): 391-400.
10. Ko M, Sohn DH, Chung H, Seong RH. Chromatin remodeling, development and disease. Mutat Res. 2008;647(1-2):59-67.
11. Winandy S. Regulation of chromatin structure during thymic T cell development. J Cell Biochem. 2005;95(3):466-477. (Pubitemid 41420177)
12. Krasteva V, Buscarlet M, Diaz-Tellez A, Bernard MA, Crabtree GR, Lessard JA. The BAF53a subunit of SWI/SNF-like BAF complexes is essential for hemopoietic stem cell function. Blood. 2012;120(24): 4720-4732.
13. Vradii D, Wagner S, Doan DN, et al. Brg1, the ATPase subunit of the SWI/SNF chromatin remodeling complex, is required for myeloid differentiation to granulocytes. J Cell Physiol. 2006;206(1):112-118. (Pubitemid 41740723)
14. Stopka T, Zakova D, Fuchs O, et al. Chromatin remodeling gene SMARCA5 is dysregulated in primitive hematopoietic cells of acute leukemia. Leukemia. 2000;14(7):1247-1252. (Pubitemid 30445032)
15. Martin-Perez D, Piris MA, Sanchez-Beato M. Polycomb proteins in hematologic malignancies. Blood. 2010;116(25):5465-5475.
16. Forrest ARR, Kawaji H, Rehli M, et al. A promoter level mammalian expression atlas. Nature. doi:10.1038/nature13182.
17. Kanamori-Katayama M, Itoh M, Kawaji H, et al. Unamplified cap analysis of gene expression on a single-molecule sequencer. Genome Res. 2011;21(7):1150-1159.
18. Pruitt KD, Tatusova T, Brown GR, Maglott DR. NCBI Reference Sequences (RefSeq): current status, new features and genome annotation policy. Nucleic Acids Res. 2012;40(Database issue):D130-D135.
19. Robinson MD, McCarthy DJ, Smyth GK. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics. 2010;26(1): 139-140.
20. Takahashi H, Lassmann T, Murata M, Carninci P. 5′ end-centered expression profiling using cap-analysis gene expression and next-generation sequencing. Nat Protoc. 2012;7(3):542-561.
21. Itoh M, Kojima M, Nagao-Sato S, et al. Automated workflow for preparation of cDNA for cap analysis of gene expression on a single molecule sequencer. PLoS ONE. 2012;7(1):e30809.
22. Novershtern N, Subramanian A, Lawton LN, et al. Densely interconnected transcriptional circuits control cell states in human hematopoiesis. Cell. 2011;144(2):296-309.
23. Bröske AM, Vockentanz L, Kharazi S, et al. DNA methylation protects hematopoietic stem cell multipotency from myeloerythroid restriction. Nat Genet. 2009;41(11):1207-1215.
24. Bhattacharya SK, Ramchandani S, Cervoni N, Szyf M. A mammalian protein with specific demethylase activity for mCpG DNA. Nature. 1999;397(6720):579-583.
25. Theilgaard-Mönch K, Jacobsen LC, Borup R, et al. The transcriptional program of terminal granulocytic differentiation. Blood. 2005;105(4): 1785-1796. (Pubitemid 40223703)
26. Moreno DA, Scrideli CA, Cortez MA, et al. Differential expression of HDAC3, HDAC7 and HDAC9 is associated with prognosis and survival in childhood acute lymphoblastic leukaemia. Br J Haematol. 2010;150(6):665-673.
27. Chauchereau A, Mathieu M, de Saintignon J, et al. HDAC4 mediates transcriptional repression by the acute promyelocytic leukaemia-associated protein PLZF. Oncogene. 2004;23(54):8777-8784. (Pubitemid 39593292)
28. Steele-Perkins G, Fang W, Yang XH, et al. Tumor formation and inactivation of RIZ1, an Rb-binding member of a nuclear protein- methyltransferase superfamily. Genes Dev. 2001;15(17):2250-2262. (Pubitemid 32843837)
29. Damm F, Oberacker T, Thol F, et al. Prognostic importance of histone methyltransferase MLL5 expression in acute myeloid leukemia. J Clin Oncol. 2011;29(6):682-689.
30. Madan V, Madan B, Brykczynska U, et al. Impaired function of primitive hematopoietic cells in mice lacking the Mixed-Lineage-Leukemia homolog MLL5. Blood. 2009;113(7):1444-1454.
31. Liu H, Westergard TD, Hsieh JJ. MLL5 governs hematopoiesis: a step closer. Blood. 2009;113(7):1395-1396.
32. Jo SY, Granowicz EM, Maillard I, Thomas D, Hess JL. Requirement for Dot1l in murine postnatal hematopoiesis and leukemogenesis by MLL translocation. Blood. 2011;117(18):4759-4768.
33. Sprüssel A, Schulte JH, Weber S, et al. Lysinespecific demethylase 1 restricts hematopoietic progenitor proliferation and is essential for terminal differentiation. Leukemia. 2012;26(9):2039-2051.
34. Schenk T, Chen WC, Göllner S, et al. Inhibition of the LSD1 (KDM1A) demethylase reactivates the all-trans-retinoic acid differentiation pathway in acute myeloid leukemia. Nat Med. 2012;18(4):605-611.
35. Saleque S, Kim J, Rooke HM, Orkin SH. Epigenetic regulation of hematopoietic differentiation by Gfi-1 and Gfi-1b is mediated by the cofactors CoREST and LSD1. Mol Cell. 2007;27(4):562-572. (Pubitemid 47238633)
36. Agger K, Cloos PA, Christensen J, et al. UTX and JMJD3 are histone H3K27 demethylases involved in HOX gene regulation and development. Nature. 2007;449(7163):731-734. (Pubitemid 47552088)
37. Liu J, Mercher T, Scholl C, Brumme K, Gilliland DG, Zhu N. A functional role for the histone demethylase UTX in normal and malignant hematopoietic cells. Exp Hematol. 2012;40(6):487-498.
38. Barak O, Lazzaro MA, Cooch NS, Picketts DJ, Shiekhattar R. A tissue-specific, naturally occurring human SNF2L variant inactivates chromatin remodeling. J Biol Chem. 2004; 279(43):45130-45138. (Pubitemid 39430928)
39. Thompson PM, Gotoh T, Kok M, White PS, Brodeur GM. CHD5, a new member of the chromodomain gene family, is preferentially expressed in the nervous system. Oncogene. 2003;22(7):1002-1011. (Pubitemid 36313144)
40. Yoshida T, Hazan I, Zhang J, et al. The role of the chromatin remodeler Mi-2beta in hematopoietic stem cell self-renewal and multilineage differentiation. Genes Dev. 2008;22(9):1174-1189. (Pubitemid 351656577)
41. Ho L, Crabtree GR. Chromatin remodelling during development. Nature. 2010;463(7280):474-484.
42. Lessard J, Wu JI, Ranish JA, et al. An essential switch in subunit composition of a chromatin remodeling complex during neural development. Neuron. 2007;55(2):201-215. (Pubitemid 47048906)
43. Gebuhr TC, Kovalev GI, Bultman S, Godfrey V, Su L, Magnuson T. The role of Brg1, a catalytic subunit of mammalian chromatin-remodeling complexes, in T cell development. J Exp Med. 2003;198(12):1937-1949. (Pubitemid 38032125)
44. Kadam S, Emerson BM. Transcriptional specificity of human SWI/SNF BRG1 and BRM chromatin remodeling complexes. Mol Cell. 2003;11(2):377-389. (Pubitemid 36293832)
45. Jin C, Kato K, Chimura T, et al. Regulation of histone acetylation and nucleosome assembly by transcription factor JDP2. Nat Struct Mol Biol. 2006;13(4):331-338. (Pubitemid 43873504)
46. Ji H, Ehrlich LI, Seita J, et al. Comprehensive methylome map of lineage commitment from haematopoietic progenitors. Nature. 2010; 467(7313):338-342.
47. Ramírez J, Hagman J. The Mi-2/NuRD complex: a critical epigenetic regulator of hematopoietic development, differentiation and cancer. Epigenetics. 2009;4(8):532-536.
48. Zeisig BB, García-Cuéllar MP, Winkler TH, Slany RK. The oncoprotein MLL-ENL disturbs hematopoietic lineage determination and transforms a biphenotypic lymphoid/myeloid cell. Oncogene. 2003;22(11):1629-1637. (Pubitemid 36408178)
49. Quesada V, Conde L, Villamor N, et al. Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia. Nat Genet. 2012;44(1):47-52.
50. Tan J, Jones M, Koseki H, et al. CBX8, a polycomb group protein, is essential for MLL-AF9-induced leukemogenesis. Cancer Cell. 2011;20(5):563-575.
51. Nakahata S, Saito Y, Hamasaki M, et al. Alteration of enhancer of polycomb 1 at 10p11.2 is one of the genetic events leading to development of adult T-cell leukemia/lymphoma. Genes Chromosomes Cancer. 2009;48(9):768-776.
52. Watkins NA, Gusnanto A, de Bono B, et al Bloodomics Consortium. A HaemAtlas: characterizing gene expression in differentiated human blood cells. Blood. 2009;113(19):e1-e9.
53. Severin J, Lizio M, Harshbarger J, et al. Interactive visualization and analysis of largescale NGS data-sets using ZENBU. Nat Biotechnol. http://dx.doi.org/10.1038/nbt.2840 (2014).
54. Yoo AS, Crabtree GR. ATP-dependent chromatin remodeling in neural development. Curr Opin Neurobiol. 2009;19(2):120-126.
55. Allantaz F, Cheng DT, Bergauer T, et al. Expression profiling of human immune cell subsets identifies miRNA-mRNA regulatory relationships correlated with cell type specific expression. PLoS ONE. 2012;7(1):e29979.
56. Medvedovic J, Ebert A, Tagoh H, Busslinger M. Pax5: a master regulator of B cell development and leukemogenesis. Adv Immunol. 2011;111:179-206.